A Study of ddI in Children With AIDS Who Have Not Had Success With Zidovudine
NCT00002280 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL
Last updated 2011-08-05
Summary
The purpose of this study is to make didanosine (ddI) available to children with AIDS who are clinically deteriorating on zidovudine (AZT) or intolerant to AZT and cannot enter the Phase II ddI programs due to protocol exclusion or geographic location.
Conditions
- HIV Infections
Interventions
- DRUG
-
Didanosine
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bristol-Myers Squibb · Bristol-Myers Squibb
Study Design
- Purpose
- TREATMENT
- Masking
- NONE
Eligibility
- Min Age
- 3 Months
- Max Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Completion
- 1994-11-30
Countries
- United States
Study Locations
More Related Trials
-
Double-Blind Comparison of the Efficacy of Continued Zidovudine Versus 2',3'-Dideoxyinosine (ddI) (BMY-40900) for the Treatment of Patients With AIDS or AIDS-Related Complex and Increasing Symptomatology Despite Treatment With Zidovudine
NCT00002035 ·Status: COMPLETED ·Phase: NA
-
A Phase II Efficacy Study Comparing 2',3'-Dideoxyinosine (ddI) (BMY-40900) and Zidovudine Therapy of Patients With HIV Infection Who Have Been on Long Term Zidovudine Treatment
NCT00000671 ·Status: COMPLETED ·Phase: PHASE2
-
The Safety of Different Dose Levels of Zidovudine in HIV-Infected Children
NCT00000983 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase I/II, Open Label Study to Evaluate the Antiviral Potential of Combination Zidovudine and 2' 3'-Dideoxyinosine (Didanosine) in Patients With Asymptomatic HIV Disease
NCT00000656 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Dideoxycytidine Plus Zidovudine (AZT) in HIV-Infected Children Who Have Taken AZT
NCT00001032 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial of Two Doses of 2',3'-Dideoxycytidine (ddC) in the Treatment of Children With Symptomatic HIV Infection Who Are Intolerant of AZT and/or Who Show Progressive Disease While on AZT
NCT00000653 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of ddI Versus Zidovudine in HIV-Infected Patients
NCT00000979 ·Status: COMPLETED ·Phase: PHASE2
-
A Multicenter Phase II Double-Blind Exploratory Study to Evaluate Differences Among Various Zidovudine/Didanosine Regimens on Quantitative Measures of Viral Burden in Relatively Early HIV-1 Infection
NCT00000823 ·Status: COMPLETED ·Phase: PHASE2
-
An Efficacy Study of 2',3'-Dideoxyinosine (ddI) (BMY-40900) Administered Orally Twice Daily to Zidovudine Intolerant Patients With AIDS or AIDS-Related Complex
NCT00000672 ·Status: COMPLETED ·Phase: PHASE2
-
A Prospective, Randomized, Open-Label, Comparative Trial of Dideoxyinosine (ddI) Versus Dideoxycytidine (ddC) in HIV-Infected Patients Who Are Intolerant of or Who Have Failed Zidovudine (AZT) Therapy
NCT00000969 ·Status: COMPLETED ·Phase: NA
-
The Antiviral Efficacy of Concurrent Zidovudine and 2',3'-Dideoxyinosine or 2',3'-Dideoxycytidine in Patients With Human Immunodeficiency Virus Disease
NCT00002001 ·Status: COMPLETED ·Phase: NA
-
The Safety and Effectiveness of Zidovudine in the Treatment of HIV-Infected Children With Mild to Moderate Symptoms
NCT00000990 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase I Trial to Evaluate Didanosine (ddI) in HIV-Infected Pregnant Women
NCT00000839 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Patients Who Have Not Had Success With Zidovudine
NCT00001025 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of WF 10 IV Solution in Patients With Advanced HIV Disease
NCT00002152 ·Status: COMPLETED ·Phase: PHASE2
-
An Open-Label Safety Program for the Use of Zalcitabine (Dideoxycytidine; ddC) in Pediatric Patients With Symptomatic HIV Infection Who Have Failed or Are Intolerant to AZT Monotherapy, or Who Have Completed Other ddC Protocols, or Are Ineligible for Other Ongoing Clinical Studies
NCT00002118 ·Status: COMPLETED ·Phase: NA
-
Dideoxycytidine ( Ro 24-2027 ). A Treatment Protocol for the Use of Dideoxycytidine ( ddC ) in Patients With AIDS or Advanced ARC Who Cannot Be Maintained on Zidovudine ( AZT ) Therapy.
NCT00002256 ·Status: COMPLETED ·Phase: NA
-
A Study of Azidothymidine in HIV-Infected Children
NCT00000982 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of 2',3'-Dideoxyinosine (Didanosine, ddI) and Zidovudine in Therapy of Patients With the AIDS Dementia Complex
NCT00000657 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial of Alternating 2',3'-Dideoxycytidine and Zidovudine in the Treatment of Patients With Advanced HIV Disease
NCT00000719 ·Status: COMPLETED ·Phase: NA
-
A Study of Nystatin in HIV-Infected Patients
NCT00002313 ·Status: COMPLETED ·Phase: PHASE1
-
Dideoxycytidine ( Ro 24-2027 ) A Randomized, Open-Label, Comparative Study of Dideoxycytidine ( ddC ) Versus Zidovudine ( AZT ) in Patients With AIDS or Advanced ARC Who Have Received Long-Term AZT Therapy.
NCT00000678 ·Status: COMPLETED ·Phase: PHASE2
-
The Safety and Effectiveness of Zidovudine (AZT) in the Treatment of HIV Infection in Patients With AIDS and Advanced ARC
NCT00000999 ·Status: COMPLETED ·Phase: PHASE1
-
A Randomized, Double Blind, Comparative Study of Dideoxycytidine (ddC) Alone or ddC/AZT Combination Versus Zidovudine (ZDV) Alone in Patients With HIV Infection Who Have Received Prior ZDV Therapy
NCT00000651 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomized, Double-Blind Phase II/III Trial of Monotherapy vs. Combination Therapy With Nucleoside Analogs in HIV-Infected Persons With CD4 Cells of 200-500/mm3
NCT00000625 ·Status: COMPLETED ·Phase: PHASE2